1. Home
  2. NIU vs DBVT Comparison

NIU vs DBVT Comparison

Compare NIU & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIU
  • DBVT
  • Stock Information
  • Founded
  • NIU 2014
  • DBVT 2002
  • Country
  • NIU China
  • DBVT France
  • Employees
  • NIU N/A
  • DBVT N/A
  • Industry
  • NIU Auto Manufacturing
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NIU Consumer Discretionary
  • DBVT Health Care
  • Exchange
  • NIU Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • NIU 275.6M
  • DBVT 289.8M
  • IPO Year
  • NIU 2018
  • DBVT N/A
  • Fundamental
  • Price
  • NIU $4.99
  • DBVT $9.99
  • Analyst Decision
  • NIU
  • DBVT Buy
  • Analyst Count
  • NIU 0
  • DBVT 4
  • Target Price
  • NIU N/A
  • DBVT $14.81
  • AVG Volume (30 Days)
  • NIU 873.5K
  • DBVT 33.5K
  • Earning Date
  • NIU 08-11-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • NIU N/A
  • DBVT N/A
  • EPS Growth
  • NIU N/A
  • DBVT N/A
  • EPS
  • NIU N/A
  • DBVT N/A
  • Revenue
  • NIU $527,760,629.00
  • DBVT $3,800,000.00
  • Revenue This Year
  • NIU $41.32
  • DBVT $1,743.46
  • Revenue Next Year
  • NIU $24.38
  • DBVT $1,044.34
  • P/E Ratio
  • NIU N/A
  • DBVT N/A
  • Revenue Growth
  • NIU 32.62
  • DBVT N/A
  • 52 Week Low
  • NIU $1.66
  • DBVT $2.21
  • 52 Week High
  • NIU $5.37
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • NIU 79.79
  • DBVT 54.55
  • Support Level
  • NIU $3.41
  • DBVT $9.33
  • Resistance Level
  • NIU $4.57
  • DBVT $10.10
  • Average True Range (ATR)
  • NIU 0.30
  • DBVT 0.68
  • MACD
  • NIU 0.15
  • DBVT 0.05
  • Stochastic Oscillator
  • NIU 80.61
  • DBVT 61.16

About NIU Niu Technologies

Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: